Highlights Net revenue grew to $6.5 billion, an increase of 10.7% compared to 2024;Adjusted EBITDA1 of $$1.1 billion, up 16.7% ...
With just two games left UCLA needs to limit these 3 Cornhuskers to save its season ...
FDA Approval for Pediatric Indication -- LINZESS received U.S. FDA approval in November 2025 for IBS-C patients aged 7-17, becoming the first and only prescription drug specifically approved for this ...
Leadership Appointment -- Stephen Tadlock named CEO of Cactus International.
Newmark Group, Inc. (NASDAQ:NMRK) Q4 2025 Earnings Call Transcript February 25, 2026 Newmark Group, Inc. misses on earnings ...
You can get crypto signals through Telegram, Discord, email, or special platforms. These are trade ideas that you can act on. They name an asset (like BTC/USDT), a direction (long or short), an entry ...
Good afternoon, everyone. It's a pleasure to have you all here today. This is our press conference for the U.S. Article IV Consultation for 2026. We hope you have had a chance to review the concluding ...
Exzeo Group, Inc. (NYSE:XZO) Q4 2025 Earnings Call Transcript February 25, 2026 Exzeo Group, Inc. beats earnings expectations. Reported EPS is $0.25, expectations were $0.13. Operator: Good afternoon, ...
The Radioligand Therapy Market is projected to reach US$13 billion by 2030, growing at an estimated rate of 5%. Key drivers of this growth include the rising incidence of cancers such as prostate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results